SCHEMBL10070517

SCHEMBL10070517

Cc1ncccc1OC(=O)N1CCC(c2nc(-c3ccc(C(F)(F)F)cc3)n[nH]2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 3/20 0.42
TRPC3 Q13507 1/20 0.40
TRPC7 Q9HCX4 1/20 0.40
CPT2 P23786 2/20 0.40
CPT1A P50416 2/20 0.40
CPT1B Q92523 1/20 0.40
TRPA1 O75762 1/20 0.39
GPR142 Q7Z601 2/20 0.39
HCRTR1 O43613 2/20 0.39
HCRTR2 O43614 2/20 0.39
P2RY12 Q9H244 1/20 0.38
FASN P49327 1/20 0.38
HSD11B1 P28845 1/20 0.38
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TLR9 Q9NR96 1/20 0.37
TLR8 Q9NR97 1/20 0.37
TLR7 Q9NYK1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10070076 0.91 KIT (0.44) TRPC3TRPC7P2RY12HSD11B1LMNA
SCHEMBL10070095 0.91 CPT2 (0.49) TRPV1CPT2CPT1ACPT1BTRPA1
SCHEMBL10070539 0.89 P2RY12 (0.47) HCRTR1HCRTR2P2RY12HSD11B1HTR2B
SCHEMBL10070552 0.89 HTR2B (0.43) TRPA1P2RY12HSD11B1TLR9TLR8
SCHEMBL10070106 0.86 CPT1A (0.46) CPT2CPT1AHCRTR1HCRTR2P2RY12
SCHEMBL10070550 0.86 CPT1A (0.40) CPT1AHCRTR1HCRTR2P2RY12HSD11B1
SCHEMBL10070536 0.84 CPT1A (0.46) CPT2CPT1ACPT1BGPR142HCRTR1
SCHEMBL10070119 0.83 LIPE (0.47) TRPV1TRPC3TRPC7TRPA1LIPE
SCHEMBL10069714 0.83 HSD11B1 (0.43) TRPA1GPR142P2RY12HSD11B1TLR9
SCHEMBL1654836 0.82 CPT2 (0.46) CPT2CPT1AHCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8207199-B2 Azole compound ASTELLAS PHARMA INC. (JP) 2012-06-26 US disclosed
US-20110118311-A1 AZOLE COMPOUND ASTELLAS PHARMA INC. (JP) 2011-05-19 US disclosed
EP-2308869-A1 AZOLE COMPOUND Astellas Pharma Inc. (JP) 2011-04-13 EP disclosed
WO-2010007966-A1 AZOLE COMPOUND アステラス製薬株式会社 (JP) 2010-01-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118311-A1 AZOLE COMPOUND FAAH, FAAH2, TRPV1 TRPV1 3/4885TRPC3 40/4885TRPC7 38/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.